New Tezepelumab Data Show 86% Reduction In Exacerbations In Patients With Severe Asthma And Comorbid Nasal Polyps ...Middle East

THOUSAND OAKS, Calif., Sept. 5, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data from the pivotal NAVIGATOR Phase 3 trial demonstrating that tezepelumab reduced exacerbations and improved lung function and nasal symptoms in patients with severe, uncontrolled asthma and...

Read More Details
Finally We wish PressBee provided you with enough information of ( New Tezepelumab Data Show 86% Reduction In Exacerbations In Patients With Severe Asthma And Comorbid Nasal Polyps )

Also on site :

• Building explodes, causes fire in Yolo County town of Esparto
• 6 Nighttime Habits of Celebrities Over 50 With Beautiful Skin
• Hollywood Legend, 99, Amazes Fans in Latest Interview